From: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
HLN | PART | MEAN | RANGE | MLN | PART | MEAN | RANGE |
---|---|---|---|---|---|---|---|
 | SF | 5% | 0–8% |  | SF | 28% | 7–41% |
HSP60 | PC | 2% | 0–4% | HSP60 | PC | 2% | 0–4% |
 | MS | 1% | 0–2% |  | MS | 3% | 0–6% |
 | SF | 13% | 4–22% |  | SF | 35% | 18–58% |
HSP10 | PC | 5% | 2–8% | HSP10 | PC | 9% | 4–19% |
 | MS | 3% | 1–5% |  | MS | 38% | 22–65% |